Cited by

• COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.

  Singh D, Watz H, Beeh KM, Kornmann O, Leaker B, Colgan B, Lucci G, Emirova A, Nandeuil MA, Santoro D, Balzano D, Govoni M. Singh D, et al. Eur Respir J. 2020 Aug 6;56(2):2000237. doi: 10.1183/13993003.00237-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32341106 Free PMC article.
• Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.

  Singh D, Bafadhel M, Brightling CE, Sciurba FC, Curtis JL, Martinez FJ, Pasquale CB, Merrill DD, Metzdorf N, Petruzzelli S, Tal-Singer R, Compton C, Rennard S, Martin UJ. Singh D, et al. Am J Respir Crit Care Med. 2020 Sep 1;202(5):660-671. doi: 10.1164/rccm.201912-2384PP. Am J Respir Crit Care Med. 2020. PMID: 32186896 Free PMC article. Review. No abstract available.
• Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases.

  Ragnoli B, Radaeli A, Pochetti P, Kette S, Morjaria J, Malerba M. Ragnoli B, et al. Ther Adv Chronic Dis. 2023 Aug 1;14:20406223231190480. doi: 10.1177/20406223231190480. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 37538344 Free PMC article. Review.
• Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis.

  Chan MC, Yeung YC, Yu ELM, Yu WC. Chan MC, et al. Int J Chron Obstruct Pulmon Dis. 2020 Nov 10;15:2869-2877. doi: 10.2147/COPD.S268018. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33204083 Free PMC article.
• Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.

  Kostikas K, Brindicci C, Patalano F. Kostikas K, et al. Curr Drug Targets. 2018;19(16):1882-1896. doi: 10.2174/1389450119666180212120012. Curr Drug Targets. 2018. PMID: 29437007 Free PMC article. Review.